MUSTANG BIO, INC. Quarterly Depreciation in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Mustang Bio, Inc. quarterly/annual Depreciation history and growth rate from Q1 2017 to Q3 2024.
  • Mustang Bio, Inc. Depreciation for the quarter ending September 30, 2024 was $100K, a 66.7% decline year-over-year.
  • Mustang Bio, Inc. Depreciation for the twelve months ending September 30, 2024 was $893K, a 61.8% decline year-over-year.
  • Mustang Bio, Inc. annual Depreciation for 2023 was $1.86M, a 31.7% decline from 2022.
  • Mustang Bio, Inc. annual Depreciation for 2022 was $2.72M, a 25.7% increase from 2021.
  • Mustang Bio, Inc. annual Depreciation for 2021 was $2.17M, a 29.2% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $893K $100K -$200K -66.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $1.09M $300K -$300K -50% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.39M $285K -$467K -62.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.86M $208K -$475K -69.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 $2.34M $300K -$400K -57.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $2.74M $600K -$100K -14.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $2.84M $752K +$112K +17.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $2.72M $683K +$78K +12.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 $2.65M $700K +$100K +16.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $2.55M $700K +$200K +40% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $2.35M $640K +$178K +38.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $2.17M $605K +$101K +20% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $2.07M $600K +$200K +50% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $1.87M $500K +$100K +25% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $1.77M $462K +$89K +23.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.68M $504K +$134K +36.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 $1.54M $400K +$100K +33.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $1.44M $400K +$100K +33.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $1.34M $373K +$85K +29.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $1.26M $370K +$47K +14.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-24
Q3 2019 $1.21M $300K +$100K +50% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $1.11M $300K +$200K +200% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $911K $288K +$281K +4014% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $630K $323K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $200K +$200K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $100K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $7K +$7K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q3 2017 $0 Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q1 2017 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2018-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.